Sidley Austin To Reveal Guidance On UK Data Protection And Pharmacovigilance, 1-2 July 2013, London, UK

Date: Jun-06-2013With just 4 weeks remaining until SMi open their doors to host the 3rd instalment in the Pharmacovigilance conference series, SMi have announced that William Long, Partner at Sidley Austin will be making a presentation on new PV policy.

The new presentation will provide:
Explanation of new UK Guidance on Data Protection and PV
Understanding of background to EU data protection and PV
Development of the UK Guidance
Outline of the scope and main elements of the UK Guidance
The conference will aim to offer delegates with guidance on the main points to consider when presenting a PSUR to external regulatory bodies and tackle the issues and importance of adverse event reporting.

Attendees include:

EMA
Abbott
Federal Agency for Medicial and Health Products
Teva
Merck Serono
Roche
Gensyme
Johnson & Johnson
Novo Nordisk
Pharsafer
NDA Regulatory Science
Eli Lilly
MorphoSys
plus many more...

"...this Pharmacovigilance event brings experienced representative stakeholders together to generate a mutually-positive dialogue and cross-fertilized consensus on understanding, sharing, benchmarking and improving the way we operate within the discipline of Pharmacovigilance" - Abbott

To find out more visit http://www.pharmacovigilance-event.com.
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.